Joondalup Health Campus is the largest health care facility in the northern suburbs of Perth, Western Australia. The 722-bed hospital has featured combined public and private services since 1996. In March 2013, the new Joondalup Private Hospital opened next to the existing hospital, within the same campus.

There are 722 beds in Joondalup Health Campus.

During the past decade, Joondalup Health Campus conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joondalup Health Campus" #1 collaborator was "Australasian College for Emergency Medicine" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Australian Government Department of Health and Ageing" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator and "Griffith University" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Joondalup Health Campus" are "Autosomal Recessive Disorder" (1 trials), "Non-small Cell Lung Cancer" (1 trials), "SARS-CoV-2 Infection (COVID-19)" (1 trials), "Severe Sepsis" (1 trials) and "X-Linked Genetic Diseases" (1 trials). Many other conditions were trialed in "Joondalup Health Campus" in a lesser frequency.

Most popular intervention types in "Joondalup Health Campus" are "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Dalteparin" (1 trials), "Early Goal Directed Therapy (EGDT)" (1 trials) and "Enoxaparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Joondalup Health Campus" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Joondalup Health Campus". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Joondalup Health Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Joondalup Health Campus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".